Replies to post #5346 on Cyclo Therapeutics Inc (CYTH)

[Lazarus]

Nope, I never try to mislead. Never ask anyone to believe anything that isnt true. Not my style.

In the mean time while you're bragging about the stock going up on small volume, have you noticed that the majority of the trades have been short sales?
Take a look

[Lazarus]

So tell us, how were the Hemples going to make hundreds of millions of dollars off Cyclodextrins?

Isn't this what CTD Holdings is attempting to do?

What was/is the relationship between CTDH and the Hemples? If CTDH suddenly went to $20.00 per share, would the Hemples go after CTDH for money?

Help me connect the dots...

This from 2009

June 12, 2009 08:00 ET

CTD Holdings Moves Ahead on Research Park Project

HIGH SPRINGS, FL--(Marketwire - June 12, 2009) - CTD Holdings, Inc. (OTCBB: CTDH) (FRANKFURT: CDJ) announced that ViStra Growth Partners, Inc. (VGP), the newly created subsidiary of CTD, has agreed to present a preliminary project plan to the CTD board of directors by year end, 2009, for the proposed "Joszef Szejtli Cyclodextrin Research Park." Mr. Louis Weltman, the President/CEO of VGP, has considerable experience with commercial property development for such purposes. Rick Strattan, the Chairman/CEO of CTDH, stated that, "This project has been on the back burner at CTDH ever since we paid off the mortgage on the 40 acre corporate site in 2007. The convergence of CTDH's work with Chris Hempel to get Trappsol® HPB into a compassionate use study for her twin girls with Niemann-Pick disease, a form of childhood Alzheimer's, and working with the expertise of Lou Weltman and his knowledge of 501(c)3 organizations has really crystallized for me what the mission of the Research Park will be."

Mr. Strattan continues, "Chris Hempel has done more in the last 18 months to introduce the worldwide public and regulatory agencies to the amazing properties of Cyclodextrins, than the entire industry has been able to do in the last 20 years."

Ms. Hempel's exploits, efforts and successes are available on the web at www.addiandcassi.com and www.webofhope.com.

--------------

THEN WE HAVE THIS FROM THE HEMPLES WEBSITE:

According to the suit, Cydan first approached the Hempels about a partnership to develop cyclodextrin in 2013.
Soon after reaching out to the Hempels and agreeing to a joint venture, Cydan formed Vtesse, a company dedicated to developing drugs for Niemann-Pick Disease Type C and other rare diseases. In April 2017, Vtesse was purchased by Sucampo Pharmaceuticals for $200 million, in large part because of the same treatment, the suit says, the Hempels were in contract to develop.

-------------

Is it not true that most investors in CTDH believe that the Hemples were cooperating with CTDH?

In the statement above we then learn that the Hemples were in discussions with Cydan in 2013 to develop a partnership.

So if the Hemples and Cydan (latter VTESSE, etc) were to form a partnership --- WHERE WOULD THAT LEAVE CTDH?

If CTDH is the clear winner in this as you suggest, WHY WERE THE HEMPLES GOING TO DO A DEAL WITH CYDAN?

Lots of questions; lots of intrigue. Should be interesting to watch.